New Delhi [India], December 9 (ANI): AstraZeneca's Evusheld (Tixagevimab co-packaged with Cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the US for the pre-exposure prophylaxis (prevention) of COVID-19, with first doses expected t
Chennai (Tamil Nadu) / Mumbai (Maharashtra) [India], December 11 (ANI/NewsVoir): As a follow up to the World AIDS Day and to commemorate the Human Rights Day 2020, on December 10, Centre for Sexuality and Health Research and Policy (C-SHaRP) and The Humsafar Trust (HST) hosted a virtual even
Washington D.C [USA], Oct 24 (ANI): In a new study, the researchers from the National Institutes of Health Experts highlighted the best implementation of HIV prevention and treatment tools along with new interventions to end the pandemic.
Washington D.C [U.S.A], May 11 (ANI): A combination drug, Pre-exposure prophylaxis (PrEP), when taken consistently once a day can reduce the chance of HIV acquisition in high-risk groups by over 85 per cent, claimed a study.
Washington D.C. [U.S.A.], June 12 (ANI): Turns out, a certain class of HIV pill may not be as potent and helpful in barring the disease as was previously conceived.